ALLOGEENEIC tumour cells which have been maintained in tissue culture are commonly used as target cells for in vitro studies of humoral and cellular antitumour immunity in man. It has been claimed (Hellstrom et al., 1971) , and assumed by many, that the capacity of an individual's lymphoid cells to inactivate such tumour cells, and the degree to which such inactivating effects can be modified by humoral factors, is a fair reflection of the way in which an individual can react against malignant cells in his or her own tumour. The principal purpose of the present study was to determine whether or not this was correct. This is obviously a question of crucial importance, because of the ever-increasing frequency with which such tests are being performed in attempts to establish in vitro correlates for human tumour progression and regression.
The results obtained show that differences in the reactivities of individuals with breast cancer against cells of their own tumours and those derived from allogeneic tissue-cultured breast tumour cells are not infrequent, and they compel one to conclude that the routine use of target cells of allogeneic origin for in vitro studies of human anti-tumour immunity is far from ideal.
MATERIALS AND METHODS
Patients.-Ten individuals (C17-26) with primary breast carcinoma were studied.
Blood (25 ml clotted and 25 ml heparinized) was obtained from each patient on the morning of surgery and prior to the administration of any pre-operative medication.
Lymphoid cell8.-Previous publications have described the solutions used in this study (Jeejeebhoy, 1974) and the procedures employed for separation of lymphoid cells on a Ficoll-Hypaque gradient and their subsequent freezing (Jeejeebhoy, 1975 (Ozzello et al., 1974) . We froze it in aliquots at subculture generation 282.
The fourth source was primary tumours. Cell suspensions from these were prepared by mechanical dissociation as previously described (Jeejeebhoy, 1975) . On some occasions (C20-26) an attempt was made to increase the number of viable tumour cells by utilizing only the interface which remained when the initial tumour cell suspension was washed and then centrifuged on FicollHypaque (sp. gr. 1-078) as described by Mavligit, Gutterman and Hersh (1973) . If the target cells which were to be used for in vitro studies were not distinctly epithelial in appearance, the experiment was not proceeded with. The difficulties involved in preparing suitable cell suspensions from primary breast tumours precluded the study of many of the tumours obtained.
A vial of each of Lines 257742, BT20 and 306462 was thawed and placed in tissue culture flasks on the day when a primary tumour was received. On the day preceding the performance of the in vitro assay, these cells were treated in the same ways and exposed to the same solutions as were the cells of the primary tumours and they were then seeded in the wells of the plastic plates as described below.
Cytotoxicity tests.-A modification of a previously described method (Takasugi and Klein, 1970) (Jeejeebhoy, 1975) , using the procedures described in this paper, have not as yet demonstrated any prozone phenomena but these do remain real possibilities. Nor have these studies shown a sequence similar to that found in mouse systems, where opposite effects occasionally result when sera are diluted (Skurzak et al., 1972) .
RESULTS

Controls
The question of what constitutes adequate controls for studies of this type is controversial. This controversy stems from the fact that lymphoid cells from apparently disease-free individuals are often cytotoxic to tumour cells in vitro (Takasugi, Mickey and Terasaki, 1973; Jeejeebhoy, 1975; Berkelhammer et al., 1975) and that sera from these same individuals can often decrease (" block " in the current terminology) or potentiate these effects by agents which seem to be immunologically specific for the tumour cells (Jeejeebhoy, 1975 Tables I and II were comparable (differences of 20% and less are rarely statistically significant in this type of in vitro cytotoxicity assay). This suggests that the results obtained represented real phenomena and were not fortuitous and unrepeatable observations. Within the framework of this basic assumption there are at least 3 questions which merit consideration.
The first is whether the data obtained represent effects directed against malignant breast epithelium, or some other cell type or types. This a question of crucial importance in the present context, but one to which a categorical answer cannot be given. One's feeling is that, for the following reasons, the results do represent effects directed against malignant breast epithelium:
(1) No experiment which involved the use of autochthonous tumour cells was proceeded with, unless the target cells were distinctly epithelial in appearance. The reasons for feeling that these epithelial cells were of malignant origin were 2-fold. Firstly, because mechanical dissociation of breast tumour fragments, as used in this study, preferentially separates infiltrating malignant epithelium. Occasionally the fragments were sectioned after processing, and areas of benign ductal epithelium, lobular carcinoma in situ and tubular carcinoma appeared intact. The procedure used seems to preferentially dissociate cells infiltrating in Indian file or in columns, and this perhaps accounts for the low and often unusably low yield of malignant cells. In this context, it should also be mentioned that almost no cells of any sort (epithelial or otherwise) are obtained when breast lumps caused by fibrocystic disease are subjected to procedures similar to those I have employed for preparing cell suspensions from fragments of malignant breast tumours. Secondly, because it has been shown that mechanical dissociation of tumour fragments results in very little dissociation of macrophages, in contrast with yields following enzymatic digestion (Evans, 1973) . Histological studies referred to above have confirmed that this is so, and that the exception also extends to fibroblasts.
(2) Lines 257742 and 306462 were used at the third subculture generation. Cells from both these lines form colonies in soft agar, and line 257742 has been subcultured to the 34th subculture generation, at which stage it was inadvertently lost. Repeated subculture was not tried with line 306462. All these facts, taken together, suggest that at least some of the cells in these 2 lines were of malignant origin. BT20 is a cell line derived from a breast adenocarcinoma (Lasfargues and Ozzello, 1958) and it forms progressively growing tumours in athymic nude mice (Ozzello et al., 1974 (Jeejeebhoy, 1975) (Hellstrom and Hellstrom, 1974) or lymphoid cells (Currie andBasham, 1972) for antibody or antigen-antibody complexes, quantitative differences in the amounts of free antibody, free antigen and/or free antigen-antibody complexes, etc. No consistent pattern of target-cell susceptibility to humoral effects was noted. It was therefore felt that further study would probably not yield any clear-cut answer, and was unlikely to be profitable.
In the context of this third question, it is noteworthy that there have been reports that lymphocyte effects against different tumour-cell lines having the same histological derivation, may not always be comparable (Mukherji et al., 1975) . The fact that they were in the present study may have been fortuitous, a consistent pattern being maintained from experiment to experiment because each of the tumour lines had been frozen in aliquots at a single point in time.
Finally, because of the problems involved in utilizing target cells derived from the autochthonous tumour, it is pertinent to ask whether those derived from allogeneic tumour-cell lines could serve as adequate substitutes. Most workers have assumed that they can (Herberman and Oldham, 1975 ) and the present results show that this is indeed acceptable, if ELAC levels are determined against not less than 3 lines, and the results not accepted unless ELAC levels against each of these 3 lines are comparable. These rather drastic caveats would have certainly eliminated all the discrepancies in the present study, but only at the cost of a large amount of labour and the failure to evaluate ELAC levels in a significant proportion of patients. Clearly then, the use of autochthonous tumour cells for determination of ELAC levels must remain the ideal.
A final note of pessimism is perhaps appropriate. The vast literature pertaining to in vitro studies of human antitumour immunity is characterized by results which are not regularly reproducible, and by correlations between in vitro data and clinical findings which are regularly demonstrable by some, and rarely by others (Herberman and Oldham, 1975) . The present paper suggests one cause for these discrepancies. 
